Citadel Advisors’s Artivion AORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.6M Buy
70,869
+43,990
+164% +$1.74M ﹤0.01% 5542
2025
Q4
$1.23M Sell
26,879
-55,973
-68% -$2.49M ﹤0.01% 6952
2025
Q3
$3.51M Sell
82,852
-70,293
-46% -$2.65M ﹤0.01% 5006
2025
Q2
$4.76M Buy
153,145
+142,269
+1,308% +$3.85M ﹤0.01% 4193
2025
Q1
$267K Buy
+10,876
New +$302K ﹤0.01% 9842
2024
Q4
Sell
-25,790
Closed -$715K 14447
2024
Q3
$687K Sell
25,790
-19,976
-44% -$519K ﹤0.01% 7586
2024
Q2
$1.17M Sell
45,766
-62,899
-58% -$1.41M ﹤0.01% 6279
2024
Q1
$2.3M Buy
108,665
+48,999
+82% +$912K ﹤0.01% 5255
2023
Q4
$1.07M Sell
59,666
-2,830
-5% -$44K ﹤0.01% 6540
2023
Q3
$947K Sell
62,496
-29,960
-32% -$485K ﹤0.01% 6666
2023
Q2
$1.59M Buy
92,456
+51,560
+126% +$759K ﹤0.01% 5575
2023
Q1
$536K Sell
40,896
-142,633
-78% -$1.82M ﹤0.01% 8158
2022
Q4
$2.22M Buy
183,529
+96,545
+111% +$1.16M ﹤0.01% 5276
2022
Q3
$1.2M Buy
86,984
+58,808
+209% +$1.18M ﹤0.01% 6590
2022
Q2
$532K Buy
28,176
+2,679
+11% +$51.7K ﹤0.01% 8501
2022
Q1
$545K Sell
25,497
-24,849
-49% -$480K ﹤0.01% 9179
2021
Q4
$1.02M Sell
50,346
-44,032
-47% -$888K ﹤0.01% 7899
2021
Q3
$2.1M Buy
94,378
+36,860
+64% +$950K ﹤0.01% 6227
2021
Q2
$1.63M Buy
+57,518
New +$1.57M ﹤0.01% 7113
2021
Q1
Sell
-25,540
Closed -$625K 13125
2020
Q4
$603K Sell
25,540
-180,537
-88% -$3.66M ﹤0.01% 7805
2020
Q3
$3.81M Buy
+206,077
New +$3.94M ﹤0.01% 3569
2020
Q2
Sell
-23,937
Closed -$508K 9723
2020
Q1
$405K Sell
23,937
-21,826
-48% -$560K ﹤0.01% 6812
2019
Q4
$1.24M Buy
+45,763
New +$1.12M ﹤0.01% 5219
2019
Q3
Sell
-43,827
Closed -$1.31M 9122
2019
Q2
$1.31M Buy
43,827
+35,819
+447% +$1.06M ﹤0.01% 5259
2019
Q1
$234K Sell
8,008
-3,459
-30% -$98.7K ﹤0.01% 7979
2018
Q4
$325K Buy
+11,467
New +$345K ﹤0.01% 7110
2018
Q3
Sell
-37,366
Closed -$1.04M 9167
2018
Q2
$1.04M Buy
37,366
+9,296
+33% +$234K ﹤0.01% 5148
2018
Q1
$563K Sell
28,070
-8,677
-24% -$166K ﹤0.01% 5692
2017
Q4
$704K Buy
+36,747
New +$736K ﹤0.01% 5163
2017
Q2
Sell
-14,746
Closed -$246K 7432
2017
Q1
$246K Sell
14,746
-7,958
-35% -$141K ﹤0.01% 6183
2016
Q4
$435K Sell
22,704
-74,976
-77% -$1.37M ﹤0.01% 5124
2016
Q3
$1.72M Buy
97,680
+83,054
+568% +$1.26M ﹤0.01% 3149
2016
Q2
$173K Buy
14,626
+163
+1% +$1.92K ﹤0.01% 5929
2016
Q1
$155K Buy
+14,463
New +$147K ﹤0.01% 5806
2015
Q4
Sell
-24,857
Closed -$242K 8695
2015
Q3
$242K Sell
24,857
-4,259
-15% -$44.5K ﹤0.01% 5875
2015
Q2
$328K Buy
29,116
+3,206
+12% +$34.1K ﹤0.01% 5623
2015
Q1
$268K Buy
+25,910
New +$285K ﹤0.01% 5810
2014
Q1
Sell
-26,809
Closed -$298K 7827
2013
Q4
$298K Buy
26,809
+24,077
+881% +$227K ﹤0.01% 4608
2013
Q3
$19K Buy
+2,732
New +$18.5K ﹤0.01% 6226

Other funds holding AORT

Citadel Advisors's AORT Position: Q1 2026 in Review

Citadel Advisors increased its Artivion (AORT) stake by 164% in Q1 2026, buying an estimated $1.74M and bringing the position to 70,869 shares worth $2.6M. The position accounts for ﹤0.01% of the portfolio, ranked #5542.

Citadel Advisors first reported a position in AORT in Q3 2013 and has held it in 39 quarters since. The position peaked at $4.76M in Q2 2025. 239 funds tracked by Wall St. Rank hold AORT as of Q1 2026.

  • Citadel Advisors held 70,869 shares of Artivion worth $2.6M as of Q1 2026.
  • Citadel Advisors bought 43,990 Artivion shares in Q1 2026, an estimated $1.74M.
  • Artivion made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #5542 holding.
  • Citadel Advisors first reported a position in Artivion in Q3 2013 and has held it in 39 quarters since.
  • Citadel Advisors's Artivion position peaked at $4.76M in Q2 2025.
  • 239 funds tracked by Wall St. Rank held Artivion as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.